Literature DB >> 6129117

Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia.

A J DiMarino, S Cohen.   

Abstract

The effect of the beta2-adrenergic agonist, carbuterol, was studied on the lower esophageal sphincter (LES) pressure in normals and in patients with achalasia. In normals, the mean LES pressure decreased from 23.1 +/- 6.2 mm Hg (mean +/- SEM) to 16.0 +/- 5.0 mm Hg at a 4.0-mg dose of carbuterol (P less than 0.05). In patients with achalasia, the mean LES pressure decreased from 50.1 +/- 5.1 mm Hg to 22.7 +/- 2.4 mm Hg after a 4.0-mg dose of carbuterol (P less than 0.01). The duration of action following oral administration exceeded 90 min. These studies indicate that the LES in man has beta2-adrenergic receptors that mediate a reduction in pressure. The magnitude of LES pressure reduction in patients with achalasia suggests that this drug may be of therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129117     DOI: 10.1007/bf01391441

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES.

Authors:  A M LANDS; T G BROWN
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  The adrenergic control of lower esophageal sphincter function: response to beta2 adrenergic agonists.

Authors:  A J Dimarino; S Cohen
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

3.  Dissociation of tracheobronchial and cardiac effects of some beta-adrenergic stimulants.

Authors:  L Hinds; R L Katz
Journal:  Anesthesiology       Date:  1971-05       Impact factor: 7.892

4.  Effects of some autonomic drugs on circular esophageal smooth muscle.

Authors:  J Christensen; E E Daniel
Journal:  J Pharmacol Exp Ther       Date:  1968-02       Impact factor: 4.030

5.  Pharmacologic identification of the lower esophageal sphincter.

Authors:  J Christensen
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

6.  Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia.

Authors:  W J Dodds; J Dent; W J Hogan; G K Patel; J Toouli; R C Arndorfer
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

7.  Response of the human cardia sphincter to circulating prostaglandins F2ALPHA and E2 and to antiinflammatory drugs.

Authors:  J B Dilawari; A Newman; J Poleo; J J Misiewicz
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

8.  Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Clinical and manometric effects of nifedipine in patients with esophageal achalasia.

Authors:  M Bortolotti; G Labò
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

10.  Genesis of basal sphincter pressure: effect of tetrodotoxin on lower esophageal sphincter pressure in opossum in vivo.

Authors:  R K Goyal; S Rattan
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

View more
  13 in total

Review 1.  Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.

Authors:  Ammar Nassri; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

2.  Prevalence of oesophagitis in asthmatics.

Authors:  S J Sontag; T G Schnell; T Q Miller; S Khandelwal; S O'Connell; G Chejfec; H Greenlee; U J Seidel; L Brand
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Effect of positions, eating, and bronchodilators on gastroesophageal reflux in asthmatics.

Authors:  S J Sontag; S O'Connell; S Khandelwal; T Miller; B Nemchausky; T G Schnell; R Serlovsky
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

4.  Gastrointestinal symptoms in patients with asthma.

Authors:  C Caffarelli; F M Deriu; V Terzi; F Perrone; G De Angelis; D J Atherton
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

Review 5.  Gastroesophageal reflux disease in children with asthma: treatment implications.

Authors:  Mark D Scarupa; Nanako Mori; Brendan J Canning
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 6.  Primary oesophageal motility disorders. Current therapeutic concepts.

Authors:  M Traube; R W McCallum
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

7.  The effects of nebulized albuterol on esophageal function in asthmatic patients.

Authors:  Brian E Lacy; Carole Mathis; John DesBiens; Mark C Liu
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

Review 8.  [Treatment of achalasia].

Authors:  Enrico P Cosentini; Etienne Wenzl; Raimund Jakesz
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

9.  Effects of beta-adrenoceptor stimulation on rectosigmoid motility in man.

Authors:  E Lyrenäs; H Abrahamsson; G Dotevall
Journal:  Dig Dis Sci       Date:  1985-06       Impact factor: 3.199

Review 10.  A controversy that has been tough to swallow: is the treatment of achalasia now digested?

Authors:  Garrett R Roll; Charlotte Rabl; Ruxandra Ciovica; Sofia Peeva; Guilherme M Campos
Journal:  J Gastrointest Surg       Date:  2009-09-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.